drugset / Trial / NCT03242967
Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Phase 3 Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects with Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Timeline
- Start
- 2017-08
- Primary completion
- 2018-02-12
- Completion
- 2018-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Darbepoetin alfa | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Vadadustat | Small molecule | — | Oral |